DPP-4 inhibitor (sitagliptin)-induced seronegative rheumatoid arthritis
Abstract
Sitagliptin is a dipeptidyl peptidase-4 inhibitor commonly used in the treatment of type 2 diabetes mellitus for glycaemic control. Concerns have arisen regarding adverse events caused by this drug, particularly concerning arthralgias. Here, we report on a 56-year-old man being treated with sitagliptin who developed inflammatory arthritis after taking the drug for 6 months. The patient presented with pain, swelling and erythema in multiple...
Paper Details
Title
DPP-4 inhibitor (sitagliptin)-induced seronegative rheumatoid arthritis
Published Date
Aug 1, 2019
Journal
Volume
12
Issue
8
Pages
e228981 - e228981
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History